← Back
$AKBA All transactions

Akebia Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$35K

Shares

25,375

Price

$1

Filed

Feb 4

Insider

Name

Burke Steven Keith

Title

SVP, Chief Medical Officer

CIK

0001619834

Roles

Officer

Transaction Details

Transaction Date

2026-02-02

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

969,133

Footnotes

This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2023. | This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2023. | This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2024. | This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2025.

Filing Info

Accession No.

0001619834-26-000002

Form Type

4

Issuer CIK

0001517022

Burke Steven Keith's History

Date Ticker Type Value
2026-02-02 AKBA $30K
2026-02-02 AKBA $35K
2026-02-02 AKBA $29K
2026-01-30 AKBA A $0
2026-01-30 AKBA A $0

Other Insiders at AKBA (90d)

Insider Bought Sold Last
Butler John P.
CEO and President
$87K $474K 2026-03-04
Burke Steven Keith
SVP, Chief Medical Officer
$59K 2026-02-02
Vickers Philip J. 2026-04-01
Grund Nicholas
Chief Commercial Officer
$118K 2026-02-02
Ostrowski Erik
SVP, CFO, CBO & Treasurer
$49K 2026-02-02
Malabre Richard C
SVP, Chief Accounting Officer
$69K 2026-02-02
Rucci Carolyn M.
SVP, Chief Legal Officer
$97K 2026-02-02